Back
Enterprise Financial Services Vs. Akero Therapeutics Industry Stock Comparison
Buy
51
EFSC
Enterprise Financial Services
Last Price:
41.88
Seasonality Move:
1.59%
Buy
75
AKRO
Akero Therapeutics
Last Price:
19.87
Seasonality Move:
2.55%
Buy
51
Enterprise Financial Services (EFSC)
is a Buy
Is Enterprise Financial Services a Buy, Sell or Hold?
- The current Enterprise Financial Services [EFSC] share price is $41.90. The Score for EFSC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- EFSC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.87. The Score for AKRO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EFSC Stock Price Chart
What is Enterprise Financial Services's stock price today?
-
The Enterprise Financial Services share price today is $41.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EFSC is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.87
The current trend is relatively stagnant and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
EFSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 70.28 | Buy |
| Chaikin Money Flow: | 28590 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.05 - 40.57) | Buy |
| Bollinger Bands (100): | (36.52 - 40.72) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 62.82 | Buy |
| Chaikin Money Flow: | 856236 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.51 - 17.91) | Buy |
| Bollinger Bands (100): | (17.18 - 49.32) | Sell |
EFSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.78 | Buy |
| 20-day SMA: | 39.33 | Buy |
| 50-day SMA: | 37.57 | Buy |
| 200-day SMA: | 41.02 | Buy |
| 8-day EMA: | 40.82 | Buy |
| 20-day EMA: | 39.52 | Buy |
| 50-day EMA: | 38.5 | Buy |
| 200-day EMA: | 40.81 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.24 | Buy |
| 20-day SMA: | 16.58 | Buy |
| 50-day SMA: | 19.62 | Buy |
| 200-day SMA: | 38.97 | Sell |
| 8-day EMA: | 18.47 | Buy |
| 20-day EMA: | 17.44 | Buy |
| 50-day EMA: | 21.56 | Sell |
| 200-day EMA: | 33.86 | Sell |
Enterprise Financial Services Earnings Growth & EFSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.45 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
Enterprise Financial Services Technical Analysis
| Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | Dec 5 | Dec 6 | Dec 7 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 28 | 29 | 30 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | Dec 5 | Dec 6 | Dec 7 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 28 | 29 | 30 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||